Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 481
interventional 328
Observational 140
Registry 13

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 131
Procedure 43
Device 29
Drug|placebo 24
Other 20
Drug|Other 14
Drug|Procedure 7
Diagnostic Test 5
Drug|Radiation 5
Radiation 5
Biological 4
Biological|Drug 4
Device|Drug 4
Biological|Drug|Other 3
Dietary Supplement|placebo 3
Dietary Supplement 2
Drug|Other|Procedure 2
Drug|placebo|Radiation 2
Other|Procedure 2
Behavioral|Drug 1
Biological|Drug|Other|Procedure|Radiation 1
Biological|Drug|Procedure|Radiation 1
Biological|Other|Procedure|Radiation 1
Biological|placebo 1
Biological|Radiation 1
Device|Drug|Other|Radiation 1
Device|Procedure 1
Device|Procedure|Radiation 1
Diagnostic Test|Drug 1
Diagnostic Test|Other 1
Diagnostic Test|Procedure 1
Dietary Supplement|Drug|placebo 1
Drug|Other|placebo 1
Drug|Other|Procedure|Radiation 1
Drug|Other|Radiation 1
Genetic 1
Other|placebo 1
Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 119
China 29
France 22
Korea, Republic of 17
NA 10
Canada 8
Italy 8
Switzerland 7
Turkey 6
Japan 5
Denmark 4
Hong Kong 4
Netherlands 4
Poland 4
United Kingdom 4
Belgium 3
Egypt 3
Germany 3
Greece 3
India 3
Sweden 3
Taiwan 3
United States|Canada 3
Brazil 2
Bulgaria 2
Iran, Islamic Republic of 2
Spain 2
Thailand 2
United States|France 2
United States|Germany|Italy 2
Australia|Austria|Belgium|Brazil|Bulgaria|Canada|China|Czechia|Denmark|Finland|Germany|Greece|India|Israel|Italy|Korea, Republic of|Poland|Russian Federation|Sweden|United Kingdom 1
Australia|New Zealand 1
Austria 1
Austria|Germany|Netherlands|Poland|Slovenia 1
Austria|Germany|Switzerland 1
Belgium|Denmark|France|Germany|Italy|Netherlands|Poland|Spain|United Kingdom 1
Belgium|Denmark|France|Norway|Spain|Sweden|Switzerland 1
China|Italy 1
Colombia 1
Cyprus 1
Czechia 1
Estonia 1
Finland 1
Ireland|Switzerland 1
Israel 1
Israel|Italy|United States|Australia|Belgium|Canada|Denmark|France|Germany|Korea, Republic of|Poland|Romania|Russian Federation|Spain|Sweden|United Kingdom 1
Netherlands|Australia|Canada|Croatia|France|Hungary|Israel|Italy|Korea, Republic of|Poland|Romania|Russian Federation|Spain|Sweden 1
Norway 1
Romania 1
Singapore 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|Czechia|Denmark|France|Germany|Italy|Japan|Korea, Republic of|Poland|Portugal|Romania|Russian Federation|Spain|Sweden|Thailand|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Croatia|Czechia|France|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Romania|Russian Federation|Spain|Taiwan|Thailand|United Kingdom 1
United States|Argentina|France|Peru|Russian Federation|Ukraine 1
United States|Australia|Austria|Belgium|Brazil|Canada|Czechia|Denmark|France|Germany|Hungary|India|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Portugal|Romania|Russian Federation|Serbia|Spain|Sweden|Switzerland 1
United States|Australia|Belgium|Brazil|Canada|China|Czechia|France|Germany|Greece|India|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|United Kingdom 1
United States|Australia|Canada 1
United States|Australia|Canada|Denmark|France|Germany|Hong Kong|Israel|Italy|Japan|Korea, Republic of|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Canada|Italy|Netherlands|Romania|Spain|Switzerland 1
United States|Australia|China|Singapore|Taiwan 1
United States|Australia|France|Italy|Poland|United Kingdom 1
United States|Austria|Belgium|Brazil|Canada|Chile|Denmark|France|Germany|Greece|India|Israel|Italy|Korea, Republic of|Netherlands|Peru|Poland|Portugal|Russian Federation|Saudi Arabia|Spain|Sweden|Switzerland|United Kingdom 1
United States|Austria|Belgium|Bulgaria|China|Denmark|France|Germany|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Saudi Arabia|Spain|Sweden|United Kingdom 1
United States|Belgium|China|France|Germany|Hong Kong|Italy|Korea, Republic of|Netherlands|Singapore|Spain|Taiwan|United Kingdom 1
United States|Brazil|China|Czechia|Denmark|France|Italy|Japan|Poland|Russian Federation|Spain|Sweden 1
United States|Canada|China|Czech Republic|India|Italy|Poland|Spain|United Kingdom 1
United States|Canada|France|Germany|Italy 1
United States|Czechia|India|Israel|Italy|Netherlands|Poland|Russian Federation|United Kingdom 1
United States|Germany|Italy|United Kingdom 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 215
2 16
3 14
4 6
5 8
6 3
7 7
8 1
9 7
10 5
11 2
12 1
13 2
14 2
15 4
17 1
19 2
21 1
22 2
23 2
24 1
25 1
26 2
27 1
28 1
30 1
33 2
34 1
42 1
50 1
61 1
66 1
81 1
84 1
86 1
92 1
96 1
114 1
130 1
140 1
143 1
154 1
155 1
253 1
1329 1

Phase

Phase Study_Count
N/A 122
Phase 2 107
Phase 3 30
Phase 1 23
Phase 4 18
Phase 1/Phase 2 13
Phase 2/Phase 3 11
Early Phase 1 4

Number of Arms

Number_of_Arms Count_of_Studies
1 142
2 139
3 14
4 12
5 2
37 1
NA 18

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 8.00 4.0000 1.00000 14.0000 1.0000 74.0000 10.0000 10.0000
1st Qu. 9.50 38.2500 15.00000 19.0000 20.0000 102.0000 61.5000 50.0000
Median 10.50 96.0000 20.50000 64.0000 35.0000 183.0000 179.0000 121.0000
Mean 10.25 301.3033 39.81818 160.3077 108.1905 238.3636 220.0667 163.2778
3rd Qu. 11.25 182.2500 38.00000 105.0000 54.0000 299.5000 376.5000 196.2500
Max. 12.00 8006.0000 216.00000 970.0000 6452.0000 560.0000 780.0000 700.0000

Trial Group Type

group_type Group_Count
Experimental 356
Active Comparator 99
Placebo Comparator 42
No Intervention 36
Other 21
NA 18
Sham Comparator 3

Intervention Model

intervention_model Study_Count
Parallel Assignment 152
Single Group Assignment 150
Crossover Assignment 12
Factorial Assignment 5
Sequential Assignment 5
NA 4

Primary Purpose

primary_purpose Study_Count
Treatment 237
Diagnostic 49
Other 11
Prevention 11
Supportive Care 8
NA 5
Health Services Research 3
Basic Science 2
Screening 2

Observational Studies

Studies by Country

Country Study_Count
United States 32
NA 13
China 10
Italy 8
France 7
Taiwan 6
Korea, Republic of 5
Turkey 5
Canada 4
Denmark 4
Egypt 4
Germany 4
Spain 4
United Kingdom 4
Switzerland 3
Israel 2
Japan 2
Kazakhstan 2
Poland 2
Slovenia 2
Belarus 1
Belgium 1
Belgium|France|Germany|Italy|Luxembourg|Netherlands|Spain|United Kingdom 1
Belgium|Italy 1
Chile 1
Czechia 1
Germany|Italy|Portugal|Spain 1
Greece 1
Netherlands 1
Norway 1
Portugal 1
Romania 1
Serbia 1
Sweden 1
Ukraine 1
United States|Algeria|Argentina|Brazil|Egypt|France|Germany|Greece|India|Japan|Lebanon|Mexico|Netherlands|Philippines|Russian Federation|Saudi Arabia|Spain|Taiwan|Turkey 1
United States|Israel 1

Sites per Study

Site_count Study_Count
1 122
2 8
3 1
5 2
7 1
9 2
10 1
16 1
30 1
34 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 65.500
Median 169.000
Mean 2000.453
3rd Qu 500.000
Max 99999.000

Observation Model

observational_model Study_Count
Cohort 65
Case-Control 16
Case-Only 16
NA 13
Case Control 12
Other 9
Ecologic or Community 5
Defined Population, Natural History 2
Defined Population 1
Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 89
Retrospective 23
Cross-Sectional 17
NA 3
Cross-Sectional, Prospective 2
Longitudinal, Retrospective/Prospective 2
Other 2
Longitudinal, Prospective 1
Longitudinal, Retrospective 1

Registries

Studies by Country

Country Study_Count
China 2
NA 2
Taiwan 2
United States 2
France 1
Ireland|United Kingdom 1
Israel 1
Poland 1
Thailand 1

Sites per Study

Site_count Study_Count
1 10
2 2
12 1

Enrollment Metrics

Measure Registries
Min 22
1st Qu 200
Median 532
Mean 2047
3rd Qu 1000
Max 12438

Registry Model

observational_model Study_Count
Cohort 7
Case-Only 5
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 12
Cross-Sectional 1

Follow-up

target_duration Study_Count
1 Year 2
2 Years 2
6 Months 2
10 Years 1
12 Months 1
13 Years 1
15 Years 1
3 Years 1
5 Years 1
52 Weeks 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT01896479 A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01896479 Active, not recruiting Exelixis 2020-09-30
NCT01882816 Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01882816 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-06-30
NCT01141309 Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer https://ClinicalTrials.gov/show/NCT01141309 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-06-30
NCT04211337 A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT04211337 Recruiting Eli Lilly and Company 2023-02-17
NCT04129411 Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation https://ClinicalTrials.gov/show/NCT04129411 Recruiting Mayo Clinic 2022-03-31
NCT03469011 A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer. https://ClinicalTrials.gov/show/NCT03469011 Recruiting AHS Cancer Control Alberta 2020-12-31
NCT03463889 Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer https://ClinicalTrials.gov/show/NCT03463889 Recruiting University of California, San Francisco 2021-12-31
NCT03377829 A Multicenter Trial of PLA vs. Surgery for Treating PTMC https://ClinicalTrials.gov/show/NCT03377829 Recruiting Ruijin Hospital 2020-12-31
NCT03360890 Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors https://ClinicalTrials.gov/show/NCT03360890 Recruiting University of Chicago 2020-06-30
NCT03331172 HIFU Reapplication in Benign Nodules https://ClinicalTrials.gov/show/NCT03331172 Completed The University of Hong Kong 2018-06-30
NCT03298867 Treatment of Graves’ Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study https://ClinicalTrials.gov/show/NCT03298867 Active, not recruiting Horizon Pharma USA, Inc. 2019-02-13
NCT03268785 Intra-operative Rapid Identification of Lymph Node and Parathyroid https://ClinicalTrials.gov/show/NCT03268785 Recruiting Xijing Hospital 2018-08-01
NCT03257930 Percutaneous Ethanol Injection for Benign Cystic Thyroid Nodules https://ClinicalTrials.gov/show/NCT03257930 Completed Assiut University 2018-07-11
NCT03246958 Nivolumab Plus Ipilimumab in Thyroid Cancer https://ClinicalTrials.gov/show/NCT03246958 Recruiting Dana-Farber Cancer Institute 2021-03-31
NCT03246659 Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC https://ClinicalTrials.gov/show/NCT03246659 Completed Azienda Ospedaliero, Universitaria Pisana 2018-11-30
NCT03244956 Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03244956 Recruiting Gustave Roussy, Cancer Campus, Grand Paris 2022-12-31
NCT03215095 RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers https://ClinicalTrials.gov/show/NCT03215095 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-07-31
NCT03211117 Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT03211117 Completed Mayo Clinic 2018-02-12
NCT03191188 A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients https://ClinicalTrials.gov/show/NCT03191188 Recruiting University of California, Irvine 2020-06-30
NCT03183752 Insulin Resistance and Metformin Use on Volume of Benign Thyroid Nodules https://ClinicalTrials.gov/show/NCT03183752 Completed Hospital Universitário Clementino Fraga Filho 2018-10-17
NCT03181100 Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03181100 Recruiting M.D. Anderson Cancer Center 2023-07-27
NCT03174925 Ultrasound Elastography in Imaging Patients With Thyroid Nodules https://ClinicalTrials.gov/show/NCT03174925 Active, not recruiting Stanford University 2020-08-15
NCT03167385 Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT03167385 Recruiting Tianjin Medical University Cancer Institute and Hospital 2019-01-31
NCT03158961 The Feasibility and Safety of the TOETVA for Benign Thyroid Nodules https://ClinicalTrials.gov/show/NCT03158961 Recruiting The University of Hong Kong 2019-05-31
NCT03149354 Prevalence of Thyroid Function Abnormalities in HIV-infected Patients https://ClinicalTrials.gov/show/NCT03149354 Recruiting Centre Hospitalier Universitaire, Amiens 2022-12-19
NCT03139747 UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone https://ClinicalTrials.gov/show/NCT03139747 Completed Abramson Cancer Center of the University of Pennsylvania 2019-10-03
NCT03131726 Treatment of Graves´Ophthalmopathy With Simvastatin (GO-DS) https://ClinicalTrials.gov/show/NCT03131726 Recruiting Lund University 2020-01-26
NCT03122496 Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT03122496 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-04-30
NCT03109847 Metformin Hydrochloride in Mitigating Side Effects of Radioactive Iodine Treatment in Patients With Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03109847 Recruiting Thomas Jefferson University 2021-06-08
NCT03106337 Diagnostic Accuracy of Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular Lesions of the Thyroid https://ClinicalTrials.gov/show/NCT03106337 Completed Massachusetts General Hospital 2012-04-30
NCT03099356 Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03099356 Recruiting University of Michigan Rogel Cancer Center 2022-05-12
NCT03072160 Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT03072160 Completed National Institutes of Health Clinical Center (CC) 2019-11-22
NCT03048877 Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03048877 Active, not recruiting Peking Union Medical College Hospital 2020-07-31
NCT03048708 Thyroid in Bariatric Surgery https://ClinicalTrials.gov/show/NCT03048708 Completed University Hospitals Coventry and Warwickshire NHS Trust 2013-12-31
NCT03037385 Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03037385 Recruiting Blueprint Medicines Corporation 2021-12-31
NCT03024151 The Effects of T4 Versus T4/T3 on Psychological Distress After Total Thyroidectomy in Thyroid Cancer Patients https://ClinicalTrials.gov/show/NCT03024151 Completed Inje University 2017-11-30
NCT03012438 NIRF for Parathyroid Visualization: a Pilot Study https://ClinicalTrials.gov/show/NCT03012438 Completed Maastricht University Medical Center 2018-02-01
NCT02981095 Effect of Bupivacaine Application on Postthyroidectomy Pain https://ClinicalTrials.gov/show/NCT02981095 Completed Istanbul University 2011-01-31
NCT02980679 A Study to Compare the Safety and Imaging Pattern of Cyclotron-produced Technetium (CTC) vs. Generator-produced Technetium (G-PERT) in People With Thyroid Disorders Who Need Surgery https://ClinicalTrials.gov/show/NCT02980679 Recruiting University of Alberta 2019-09-30
NCT02966093 A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China https://ClinicalTrials.gov/show/NCT02966093 Active, not recruiting Eisai Inc. 2019-07-31
NCT02951000 Platysma Trial - Platysma Suturing Versus no Sutures for Wound Closure After Primary Thyroid Surgery https://ClinicalTrials.gov/show/NCT02951000 Completed University Hospital Tuebingen 2016-11-30
NCT02950142 Evidence-based Laboratory Test Order Sets in Primary Care https://ClinicalTrials.gov/show/NCT02950142 Completed Universitaire Ziekenhuizen Leuven 2018-06-01
NCT02947035 Molecular Testing to Direct Extent of Initial Thyroid Surgery https://ClinicalTrials.gov/show/NCT02947035 Recruiting University of Pittsburgh 2022-02-01
NCT02943980 Influenced the Type of Laryngoscopy the Intraoperative Nerve Monitoring During Thyroid Surgery https://ClinicalTrials.gov/show/NCT02943980 Completed Johannes Gutenberg University Mainz 2018-05-31
NCT02878044 Shared Decision Making in Patients With Thyroid Nodules https://ClinicalTrials.gov/show/NCT02878044 Recruiting Mayo Clinic 2021-04-30
NCT02870569 Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT02870569 Completed Suzhou Zelgen Biopharmaceuticals Co.,Ltd 2018-07-02
NCT02856347 Prospective Study Evaluating the Medullary Thyroid Cancer Management’s Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin https://ClinicalTrials.gov/show/NCT02856347 Recruiting Institut Claudius Regaud 2021-04-30
NCT02847780 Comparison of Two Technique for Assessment of Vocal Cord Movement by C-Mac Videolaryngoscope vs Airway Ultrasound. https://ClinicalTrials.gov/show/NCT02847780 Completed Rajiv Gandhi Cancer Institute & Research Center, India 2017-07-19
NCT02845336 Celecoxib for Thyroid Eye Disease https://ClinicalTrials.gov/show/NCT02845336 Recruiting Johns Hopkins University 2020-07-31
NCT02832960 The TRUST Trial - CardioVascular Imaging ECHO https://ClinicalTrials.gov/show/NCT02832960 Completed University Hospital Inselspital, Berne 2016-12-31
NCT02832934 The TRUST Study - CardioVascular Imaging IMT https://ClinicalTrials.gov/show/NCT02832934 Completed University Hospital Inselspital, Berne 2016-12-31
NCT02784223 Diagnostic Value of 18F-Choline PET/CT in Patients With a Thyroid Nodule With an Indeterminate Cytology: Pilot Study https://ClinicalTrials.gov/show/NCT02784223 Completed Centre Francois Baclesse 2019-03-28
NCT02758158 Tri-modal Imaging Instrument for Thyroid Cancer https://ClinicalTrials.gov/show/NCT02758158 Completed University Health Network, Toronto 2017-02-28
NCT02747888 Hereditary Risk Factors for Thyroid Cancer https://ClinicalTrials.gov/show/NCT02747888 Recruiting Dana-Farber Cancer Institute 2021-03-01
NCT02731352 Study of Apatinib in Patients With Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT02731352 Active, not recruiting Peking Union Medical College Hospital 2020-02-27
NCT02726503 Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT02726503 Completed Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2020-02-25
NCT02724176 Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT02724176 Completed Beijing Cancer Hospital 2016-01-31
NCT02714946 Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules https://ClinicalTrials.gov/show/NCT02714946 Active, not recruiting Campus Bio-Medico University 2019-09-30
NCT02688608 Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT02688608 Recruiting University of Texas Southwestern Medical Center 2020-10-31
NCT02658552 A Prospective Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Benign Thyroid Nodules https://ClinicalTrials.gov/show/NCT02658552 Completed The University of Hong Kong 2016-02-29
NCT02657551 A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT02657551 Recruiting Dana-Farber Cancer Institute 2020-12-31
NCT02614495 Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT02614495 Completed Hutchison Medipharma Limited 2018-09-30
NCT02609685 Active Surveillance of Papillary Thyroid Microcarcinoma https://ClinicalTrials.gov/show/NCT02609685 Recruiting Cedars-Sinai Medical Center 2030-12-31
NCT02602717 The Evaluation of the Diagnostic Properties of Intra-operative In-situ Thyroglobin Levels of Cervical Lymph Nodes, in the Discrimination Between Benign and Malignant Lymph Nodes in Thyroid Cancer: a Prospective Multicentre Study. https://ClinicalTrials.gov/show/NCT02602717 Recruiting Assistance Publique Hopitaux De Marseille 2017-05-17
NCT02592356 Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer https://ClinicalTrials.gov/show/NCT02592356 Active, not recruiting M.D. Anderson Cancer Center 2020-11-30
NCT02586350 Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031) https://ClinicalTrials.gov/show/NCT02586350 Completed Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 2018-09-30
NCT02586337 Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032) https://ClinicalTrials.gov/show/NCT02586337 Active, not recruiting Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 2019-12-31
NCT04124705 A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants https://ClinicalTrials.gov/show/NCT04124705 Recruiting Allergan 2021-09-01
NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) https://ClinicalTrials.gov/show/NCT02465060 Recruiting National Cancer Institute (NCI) 2022-06-30
NCT02561533 Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT02561533 Completed University of Aarhus 2017-07-31
NCT03196518 Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer https://ClinicalTrials.gov/show/NCT03196518 Recruiting Memorial Sloan Kettering Cancer Center 2022-06-30
NCT02515084 Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT02515084 Completed Centre Henri Becquerel 2015-07-31
NCT02500342 Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism https://ClinicalTrials.gov/show/NCT02500342 Completed University Hospital Inselspital, Berne 2018-04-05
NCT02491502 Treatment of Benign Thyroid Nodules With FastScan HIFU https://ClinicalTrials.gov/show/NCT02491502 Active, not recruiting Theraclion 2020-04-30
NCT02491008 Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction https://ClinicalTrials.gov/show/NCT02491008 Completed University Hospital Inselspital, Berne 2016-12-31
NCT02456701 Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379 https://ClinicalTrials.gov/show/NCT02456701 Completed Celldex Therapeutics 2016-10-13
NCT02418390 The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT02418390 Recruiting Seoul National University Hospital 2022-02-28
NCT02418247 Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT02418247 Active, not recruiting National Cancer Center, Korea 2017-12-31
NCT02408887 Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT02408887 Completed National Institutes of Health Clinical Center (CC) 2019-05-07
NCT02398721 Study on HRQOL and Cost-effectiveness Analysis in Management of Patients With <2cm Thyroid Nodules https://ClinicalTrials.gov/show/NCT02398721 Completed The University of Hong Kong 2017-07-31
NCT02395146 Neural Monitoring of the Superior Laryngeal Nerve in Thyroid Surgery https://ClinicalTrials.gov/show/NCT02395146 Completed The Royal Wolverhampton Hospitals NHS Trust 2018-10-01
NCT02393690 Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT02393690 Active, not recruiting Academic and Community Cancer Research United 2021-02-01
NCT02393183 The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED) https://ClinicalTrials.gov/show/NCT02393183 Recruiting Iran University of Medical Sciences 2022-06-15
NCT02390934 Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT02390934 Completed Gustave Roussy, Cancer Campus, Grand Paris 2019-04-02
NCT02378233 Iodine Status in Swedish Lactating Women - Effect of Iodine Supplementation in the Thyroid Function of Mother and Infant https://ClinicalTrials.gov/show/NCT02378233 Recruiting Göteborg University 2019-06-30
NCT02363647 Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer https://ClinicalTrials.gov/show/NCT02363647 Enrolling by invitation Icahn School of Medicine at Mount Sinai 2020-01-31
NCT02304757 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Decreased Bone Mineral Density https://ClinicalTrials.gov/show/NCT02304757 Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2020-06-30
NCT02304172 The Efficacy and Safety of Thunderbeat in Thyroid Surgery https://ClinicalTrials.gov/show/NCT02304172 Completed Seoul National University Hospital 2015-12-31
NCT02278198 Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123 https://ClinicalTrials.gov/show/NCT02278198 Completed University of Colorado, Denver 2019-09-20
NCT02258347 HIFU in Patients With Non-malignant Thyroid Nodules https://ClinicalTrials.gov/show/NCT02258347 Completed Theraclion 2015-10-13
NCT02246504 Registry - Use of a High Intensity Focused Ultrasound (HIFU) in Patients With Non-malignant Thyroid Nodules. https://ClinicalTrials.gov/show/NCT02246504 Completed Theraclion 2017-03-07
NCT02244463 A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT02244463 Recruiting Dana-Farber Cancer Institute 2020-12-31
NCT02208544 FDG-PET/CT in Evaluation of Cytological Indeterminate Thyroid Nodules to Prevent Unnecessary Surgery (EfFECTS) https://ClinicalTrials.gov/show/NCT02208544 Active, not recruiting Radboud University 2020-07-01
NCT02205801 Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy https://ClinicalTrials.gov/show/NCT02205801 Completed University of Chicago 2017-02-10
NCT02156362 Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis) https://ClinicalTrials.gov/show/NCT02156362 Recruiting Hospices Civils de Lyon 2023-05-31
NCT02155049 Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues https://ClinicalTrials.gov/show/NCT02155049 Completed Rabin Medical Center 2017-05-31
NCT02152995 Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT02152995 Recruiting National Cancer Institute (NCI) 2020-12-31
NCT02152137 Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT02152137 Active, not recruiting Alliance for Clinical Trials in Oncology 2019-02-27
NCT02150772 The Diagnostic Value of Shear Wave Elastography https://ClinicalTrials.gov/show/NCT02150772 Completed University of Aarhus 2016-03-31
NCT02145143 Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study https://ClinicalTrials.gov/show/NCT02145143 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-05-31
NCT02143726 Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer https://ClinicalTrials.gov/show/NCT02143726 Active, not recruiting Alliance for Clinical Trials in Oncology 2020-08-31
NCT02138214 Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer https://ClinicalTrials.gov/show/NCT02138214 Active, not recruiting University of Wisconsin, Madison 2019-10-30
NCT02114658 Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients https://ClinicalTrials.gov/show/NCT02114658 Completed Bayer 2015-02-23
NCT02107794 Shared Decision Making in Graves Disease - Graves Disease (GD) Choice https://ClinicalTrials.gov/show/NCT02107794 Completed Mayo Clinic 2015-04-30
NCT02088645 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer. https://ClinicalTrials.gov/show/NCT02088645 Recruiting University Hospital, Basel, Switzerland 2021-12-31
NCT02084732 Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study https://ClinicalTrials.gov/show/NCT02084732 Completed Instituto Nacional de Cancerologia, Columbia 2019-11-01
NCT01298323 Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment https://ClinicalTrials.gov/show/NCT01298323 Active, not recruiting Sanofi 2013-04-30
NCT01297699 Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease) https://ClinicalTrials.gov/show/NCT01297699 Completed Hospital Clinico Universitario de Santiago 2015-10-31
NCT01292044 The Role of Elastography in the Diagnosis of Thyroid Nodules https://ClinicalTrials.gov/show/NCT01292044 Completed Centre Hospitalier Universitaire de Nīmes 2014-08-31
NCT01273714 Subtotal Versus Total Thyroidectomy for Benign Goiter https://ClinicalTrials.gov/show/NCT01273714 Completed Jagiellonian University 2004-12-31
NCT01270321 Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01270321 Completed Emory University 2019-02-28
NCT02055989 A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx https://ClinicalTrials.gov/show/NCT02055989 Completed Royal Marsden NHS Foundation Trust 2011-12-31
NCT02041260 A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting https://ClinicalTrials.gov/show/NCT02041260 Active, not recruiting Abramson Cancer Center of the University of Pennsylvania 2020-03-31
NCT03359668 CT Detection of Metastatic Lymphadenopathy in Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT03359668 Completed University Health Network, Toronto 2017-04-20
NCT02018276 Effect of Perioperative Intravenous Lidocaine Infusion and Magnesium Infusion on the Functional Recovery After General Anesthesia in the Patients Undergoing Thyroid Surgery https://ClinicalTrials.gov/show/NCT02018276 Completed Yonsei University 2014-10-31
NCT01964144 An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer https://ClinicalTrials.gov/show/NCT01964144 Completed Yonsei University 2014-10-31
NCT01947023 Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT01947023 Active, not recruiting National Cancer Institute (NCI) 2020-07-01
NCT01937520 Acupuncture for Reduction of Inflammation https://ClinicalTrials.gov/show/NCT01937520 Completed Rutgers, The State University of New Jersey 2014-07-31
NCT01927887 Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study https://ClinicalTrials.gov/show/NCT01927887 Completed Massachusetts General Hospital 2015-04-30
NCT01916018 Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. https://ClinicalTrials.gov/show/NCT01916018 Completed Assistance Publique - Hôpitaux de Paris 2017-03-17
NCT01880203 Diagnostic Value of Molecular Cytological Analysis (CMA) and Shear Wave Elastography ShearWave (SWE) in Patients With a Thyroid Nodule With Indeterminate Cytology: Feasibility Study https://ClinicalTrials.gov/show/NCT01880203 Completed Centre Francois Baclesse 2015-09-30
NCT01876784 Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT01876784 Active, not recruiting Sanofi 2015-08-30
NCT01868997 Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease https://ClinicalTrials.gov/show/NCT01868997 Completed Horizon Pharma USA, Inc. 2016-03-31
NCT01856920 QUILT-3.006 for Recurrent Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01856920 Active, not recruiting NantCell, Inc. 2019-12-31
NCT01848171 Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism https://ClinicalTrials.gov/show/NCT01848171 Active, not recruiting Shandong Provincial Hospital 2023-07-31
NCT01840332 Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT01840332 Completed University of Tartu 2014-02-28
NCT01837745 Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients? https://ClinicalTrials.gov/show/NCT01837745 Recruiting Gustave Roussy, Cancer Campus, Grand Paris 2020-04-30
NCT01833650 The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer https://ClinicalTrials.gov/show/NCT01833650 Completed Cyprus University of Technology 2018-08-31
NCT01831869 Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism https://ClinicalTrials.gov/show/NCT01831869 Active, not recruiting Shandong Provincial Hospital 2022-04-30
NCT01813136 Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT01813136 Completed Centre Leon Berard 2019-01-31
NCT01811212 Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer https://ClinicalTrials.gov/show/NCT01811212 Completed National Cancer Institute (NCI) 2015-07-13
NCT01805856 Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery https://ClinicalTrials.gov/show/NCT01805856 Completed Ito Hospital 2012-05-31
NCT01798966 Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye Disease https://ClinicalTrials.gov/show/NCT01798966 Completed Sensimed AG 2013-06-30
NCT01776385 The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma https://ClinicalTrials.gov/show/NCT01776385 Completed Centre Hospitalier Universitaire de Nice 2017-12-31
NCT01765686 Comparing Harmonic Ultrasonic Scalpel to Small Jaw Bipolar Device in Thyroid Surgery https://ClinicalTrials.gov/show/NCT01765686 Completed National Cancer Centre, Singapore 2016-06-30
NCT01752283 Video-assisted Thyroid Surgery and Hypnosis in Thyroid Surgery https://ClinicalTrials.gov/show/NCT01752283 Completed Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2011-12-31
NCT01738243 Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease https://ClinicalTrials.gov/show/NCT01738243 Recruiting University of California, Los Angeles 2021-03-31
NCT01730638 ImmunoTEP for Patients With Medullary Thyroid Carcinoma. https://ClinicalTrials.gov/show/NCT01730638 Completed Nantes University Hospital 2016-12-31
NCT01728623 A Study of E7080 in Subjects With Advanced Thyroid Cancer https://ClinicalTrials.gov/show/NCT01728623 Completed Eisai Inc. 2015-07-31
NCT01727973 Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves’ Orbitopathy https://ClinicalTrials.gov/show/NCT01727973 Completed Sun Yat-sen University 2013-11-30
NCT01723202 Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer https://ClinicalTrials.gov/show/NCT01723202 Active, not recruiting Ohio State University Comprehensive Cancer Center 2020-12-31
NCT01709435 Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT01709435 Completed National Cancer Institute (NCI) 2018-12-31
NCT01709292 Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer https://ClinicalTrials.gov/show/NCT01709292 Active, not recruiting M.D. Anderson Cancer Center 2020-11-30
NCT01696305 Study for Hyalobarrier to Evaluate Anti-adhesive Effect and Safety Compared to Guardix-SG After Thyroidectomy https://ClinicalTrials.gov/show/NCT01696305 Completed Green Cross Corporation 2014-01-31
NCT01661179 Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT01661179 Completed Sanofi 2013-12-31
NCT01655719 Pioglitazone in Thyroid Cancers https://ClinicalTrials.gov/show/NCT01655719 Completed University of Michigan 2017-03-31
NCT01649206 Percutaneous Radiofrequency Thermal Ablation in Compressive Thyroid Nodules https://ClinicalTrials.gov/show/NCT01649206 Completed Federico II University 2011-01-31
NCT01625520 SOM230 Alone or in Combination With RAD001 in Patients With Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01625520 Completed Federico II University 2016-03-31
NCT01616316 Efficacy of Subfascial Approach in Thyroidectomy to Quality of Life in Thyroid Disease Patients https://ClinicalTrials.gov/show/NCT01616316 Completed Samsung Medical Center 2012-01-31
NCT01609946 Realtime-Elastography (RTE) and Thyroid Nodules https://ClinicalTrials.gov/show/NCT01609946 Completed Johann Wolfgang Goethe University Hospital 2013-12-31
NCT01599273 Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections https://ClinicalTrials.gov/show/NCT01599273 Completed Yonsei University 2014-08-31
NCT01579539 The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy https://ClinicalTrials.gov/show/NCT01579539 Completed Medical University of Vienna 2017-05-18
NCT01552434 Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease https://ClinicalTrials.gov/show/NCT01552434 Recruiting M.D. Anderson Cancer Center 2020-03-31
NCT01534897 Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436 https://ClinicalTrials.gov/show/NCT01534897 Completed Massachusetts General Hospital 2014-03-31
NCT01510002 Prophylactic Central Neck Dissection for Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01510002 Completed Jagiellonian University 2011-09-30
NCT01502410 Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer https://ClinicalTrials.gov/show/NCT01502410 Completed National Cancer Institute (NCI) 2014-06-30
NCT01496313 To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01496313 Active, not recruiting Sanofi 2014-04-30
NCT01438554 Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01438554 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2016-04-30
NCT01437254 To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer https://ClinicalTrials.gov/show/NCT01437254 Completed AHS Cancer Control Alberta 2012-04-30
NCT01413113 Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT01413113 Completed University of Washington 2013-11-30
NCT01398085 IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients https://ClinicalTrials.gov/show/NCT01398085 Recruiting University College, London 2020-11-30
NCT01341886 Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT01341886 Completed Mashhad University of Medical Sciences 2011-04-30
NCT01335828 Elastography Interest in the Management of Thyroid Nodules https://ClinicalTrials.gov/show/NCT01335828 Completed University Hospital, Grenoble 2012-10-31
NCT01321554 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC) https://ClinicalTrials.gov/show/NCT01321554 Completed Eisai Inc. 2013-11-15
NCT04425512 Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy https://ClinicalTrials.gov/show/NCT04425512 Completed Kahramanmaras Sutcu Imam University 2019-11-01
NCT04424485 Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy https://ClinicalTrials.gov/show/NCT04424485 Recruiting Umraniye Education and Research Hospital 2021-06-01
NCT04410601 Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT https://ClinicalTrials.gov/show/NCT04410601 Recruiting Umraniye Education and Research Hospital 2021-06-30
NCT04344886 Optimization and Individualization of Diagnostic Scintigraphy Protocol and Minimally Invasive Radio-guided Parathyroid Surgery https://ClinicalTrials.gov/show/NCT04344886 Recruiting University Hospital Ostrava 2020-11-30
NCT04336696 Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0? https://ClinicalTrials.gov/show/NCT04336696 Recruiting Zagazig University 2020-04-03
NCT04312087 Lateral Neck Lymph Node Mapping in Thyroid Cancer https://ClinicalTrials.gov/show/NCT04312087 Recruiting Fudan University 2021-08-01
NCT04309136 Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer https://ClinicalTrials.gov/show/NCT04309136 Recruiting Fudan University 2021-06-01
NCT04290663 Systematic Radioiodine Administration (3.7 GBq I131 After rhTSH) Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up https://ClinicalTrials.gov/show/NCT04290663 Recruiting Centre Francois Baclesse 2026-02-28
NCT04281875 Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy. https://ClinicalTrials.gov/show/NCT04281875 Recruiting Vanderbilt-Ingram Cancer Center 2021-03-31
NCT04280081 A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation https://ClinicalTrials.gov/show/NCT04280081 Recruiting Eli Lilly and Company 2021-05-31
NCT04248166 Thyroid Cancer and Photoacoustic Imaging https://ClinicalTrials.gov/show/NCT04248166 Recruiting Seoul St. Mary’s Hospital 2020-06-30
NCT04238624 Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT04238624 Recruiting Memorial Sloan Kettering Cancer Center 2022-06-20
NCT04230915 Low-dose Rocuronium Effect Neural Monitoring in Thyroid Surgery https://ClinicalTrials.gov/show/NCT04230915 Enrolling by invitation Bakirkoy Dr. Sadi Konuk Research and Training Hospital 2020-04-29
NCT04180007 Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers https://ClinicalTrials.gov/show/NCT04180007 Recruiting Nanjing First Hospital, Nanjing Medical University 2020-04-10
NCT04137185 Clinical Study of rhTSH in the Treatment of Patients With Thyroid Cancer After Resection of Stage I/II https://ClinicalTrials.gov/show/NCT04137185 Recruiting Suzhou Zelgen Biopharmaceuticals Co.,Ltd 2020-06-30
NCT04129281 Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma https://ClinicalTrials.gov/show/NCT04129281 Recruiting National Cancer Institute, Naples 2022-01-23
NCT04115514 Treatment of ARDS With Instilled T3 https://ClinicalTrials.gov/show/NCT04115514 Recruiting University of Minnesota 2020-10-10
NCT04051099 Bilateral Superficial Cervical Plexus Block in Thyroid/Parathyroid Surgery https://ClinicalTrials.gov/show/NCT04051099 Recruiting Mahidol University 2019-09-30
NCT04019509 The Influence of Different Thyroid Autoantibodies on Thyroid Function and Pregnancy Outcome After Assisted Reproductive Technology https://ClinicalTrials.gov/show/NCT04019509 Recruiting Universitair Ziekenhuis Brussel 2022-01-01
NCT04013308 Iontophoresis With Potassium Iodide and Thyroid Function https://ClinicalTrials.gov/show/NCT04013308 Completed University of Rzeszow 2019-07-30
NCT03977207 A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients https://ClinicalTrials.gov/show/NCT03977207 Recruiting University of California, Irvine 2024-06-30
NCT03969108 Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment https://ClinicalTrials.gov/show/NCT03969108 Completed University Health Network, Toronto 2019-11-12
NCT03948191 99Tc-MDP for Thyroid-Associated Ophthalmopathy https://ClinicalTrials.gov/show/NCT03948191 Completed Dalian University 2018-12-30
NCT03922282 BABA Robotic Thyroidectomy Without Gas is Safe Enough as That Use a Gas https://ClinicalTrials.gov/show/NCT03922282 Completed Inje University 2018-08-31
NCT03914300 Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03914300 Recruiting National Cancer Institute (NCI) 2021-01-15
NCT03911232 The Improvement of Intraoperative Neuromonitoring of Recurrent Laryngeal Nerve https://ClinicalTrials.gov/show/NCT03911232 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2016-03-31
NCT03910504 Anaesthesia With or Without Rocuronium in Intubation and Intraoperative Nerve-monitoring During Thyroid Surgery. https://ClinicalTrials.gov/show/NCT03910504 Recruiting University Magna Graecia 2020-04-17
NCT03899792 A Study of Oral LOXO-292 in Pediatric Patients With Advanced Solid or Primary Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT03899792 Recruiting Loxo Oncology, Inc. 2021-11-30
NCT03892993 Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers https://ClinicalTrials.gov/show/NCT03892993 Recruiting M.D. Anderson Cancer Center 2020-07-31
NCT03891043 Oral Supplementation With Selenium in Patients With Mild Thyroid Orbitopathy https://ClinicalTrials.gov/show/NCT03891043 Completed Instituto de Oftalmología Fundación Conde de Valenciana 2016-04-30
NCT03869398 Does Preoperative Calcium and Calcitriol Decrease Rates of Post Thyroidectomy Hypocalcemia? https://ClinicalTrials.gov/show/NCT03869398 Completed Lahey Clinic 2019-07-01
NCT03845647 Significance of Contralateral Central Lymph Node Dissection in Unilateral cN0 Differentiated Thyroid Carcinoma. https://ClinicalTrials.gov/show/NCT03845647 Recruiting Fifth Affiliated Hospital, Sun Yat-Sen University 2020-01-28
NCT03841617 The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03841617 Recruiting National Institutes of Health Clinical Center (CC) 2024-02-01
NCT03830242 Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer. https://ClinicalTrials.gov/show/NCT03830242 Recruiting Fifth Affiliated Hospital, Sun Yat-Sen University 2019-12-31
NCT03826680 Modified Cormack Lehane Scores Evaluated by Laryngoscopy During Awake Versus Under General Anesthesia https://ClinicalTrials.gov/show/NCT03826680 Recruiting Istanbul University 2020-06-30
NCT03808779 A Multicenter Trial of Radiofrequency Ablation vs. Surgery as Treatment of Papillary Thyroid Microcarcinoma. https://ClinicalTrials.gov/show/NCT03808779 Recruiting Second Affiliated Hospital, School of Medicine, Zhejiang University 2024-02-01
NCT03794375 Primary Care Transfer for Thyroid Cancer Patients https://ClinicalTrials.gov/show/NCT03794375 Enrolling by invitation Hospital de Clinicas de Porto Alegre 2020-12-31
NCT03777033 Systematic Administration of Calcium and Vitamin D After Thyroidectomy https://ClinicalTrials.gov/show/NCT03777033 Recruiting Hellenic Red Cross Hospital 2020-04-01
NCT03772496 Diagnostic Significance of CTCs in Patients With Thyroid Nodules (Circulating Tumor Cells) https://ClinicalTrials.gov/show/NCT03772496 Recruiting Cancer Institute and Hospital, Chinese Academy of Medical Sciences 2019-12-20
NCT03757637 Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer Patients https://ClinicalTrials.gov/show/NCT03757637 Recruiting National Taiwan University Hospital 2021-07-31
NCT03753919 Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial https://ClinicalTrials.gov/show/NCT03753919 Recruiting Grupo Espanol de Tumores Neuroendocrinos 2020-12-31
NCT03732495 Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas https://ClinicalTrials.gov/show/NCT03732495 Recruiting Centre Leon Berard 2021-12-15
NCT03690388 A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior VEGFR-targeted Therapy https://ClinicalTrials.gov/show/NCT03690388 Recruiting Exelixis 2020-07-31
NCT03689413 Adequate Dosage of Sugammadex on Thyroid Surgery https://ClinicalTrials.gov/show/NCT03689413 Completed Seoul National University Hospital 2019-08-28
NCT03680222 Effect of Reversed Tracking Method for Identification of EBSLN in Thyroid Surgery https://ClinicalTrials.gov/show/NCT03680222 Recruiting Fujian Medical University 2019-09-30
NCT03647657 177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT03647657 Recruiting University Hospital, Basel, Switzerland 2020-06-30
NCT03647358 Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT03647358 Recruiting Memorial Sloan Kettering Cancer Center 2022-08-31
NCT03646383 Study of the Feasibility of Radiofrequency Ablation of Benign Thyroid Nodules https://ClinicalTrials.gov/show/NCT03646383 Recruiting University Hospital, Toulouse 2021-07-31
NCT03640247 Pain Medications Following Thyroidectomy and Parathyroidectomy https://ClinicalTrials.gov/show/NCT03640247 Completed MetroHealth Medical Center 2019-12-01
NCT03630120 Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer https://ClinicalTrials.gov/show/NCT03630120 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2020-12-31
NCT03602495 Donafenib in 131I-Refractory Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03602495 Recruiting Suzhou Zelgen Biopharmaceuticals Co.,Ltd 2020-12-31
NCT03577951 Comparing the Establishment of Operation Space Between High Position and Low Position in Endoscopic Thyroid Surgery https://ClinicalTrials.gov/show/NCT03577951 Recruiting Fujian Medical University 2018-08-31
NCT03547648 Effect of Three Different Peak Airway Pressures on Determining Intraoperative Bleeding in Thryroidectomies https://ClinicalTrials.gov/show/NCT03547648 Completed Istanbul University 2018-11-16
NCT03535974 Efficacy of a Spirulina Supplement for Amelioration of Benign ThYroid Nodules https://ClinicalTrials.gov/show/NCT03535974 Completed Fundatia Bio-Forum 2018-12-20
NCT03530033 Lidocaine Reduces Muscle Tremor is Beneficial for Intraoperative Recurrent Laryngeal Nerve Monitoring https://ClinicalTrials.gov/show/NCT03530033 Recruiting Fujian Medical University 2018-10-31
NCT03517579 Personalized Treatment in Thyroid Disorders https://ClinicalTrials.gov/show/NCT03517579 Recruiting Johns Hopkins University 2020-10-15
NCT03506048 Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03506048 Recruiting Emory University 2021-01-31
NCT03498183 Value of the Combination Ultrasonography With Ti-RADS Score / Dual Tracer Scintigraphy MIBI-Tc99m/Iodine-123 in the Detection of Malignancy of Thyroid Nodules (≥15 mm) Classified Bethesda III or IV on Cytology https://ClinicalTrials.gov/show/NCT03498183 Recruiting Nantes University Hospital 2021-07-01
NCT03470259 Precision Thyroid Cancer Surgery With Molecular Fluorescent Guided Imaging https://ClinicalTrials.gov/show/NCT03470259 Completed University Medical Center Groningen 2019-12-31
NCT03469310 Minimizing Narcotic Analgesics After Endocrine Surgery https://ClinicalTrials.gov/show/NCT03469310 Active, not recruiting Doctors Hospital at Renaissance 2019-12-21
NCT03454464 Evaluation of Central Compartment Dissection Without Thyroidectomy https://ClinicalTrials.gov/show/NCT03454464 Recruiting Fujian Medical University 2018-12-31
NCT03432299 Radiofrequency Ablation of Low Risk Papillary Thyroid Microcarcinoma https://ClinicalTrials.gov/show/NCT03432299 Recruiting Seoul National University Hospital 2020-11-27
NCT03420963 Ex-Vivo Expanded Allogeneic NK Cells For The Treatment Of Pediatric Solid Tumors https://ClinicalTrials.gov/show/NCT03420963 Recruiting M.D. Anderson Cancer Center 2022-12-01
NCT03411187 Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy https://ClinicalTrials.gov/show/NCT03411187 Recruiting Fujian Medical University 2018-06-30
NCT01263951 Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone https://ClinicalTrials.gov/show/NCT01263951 Completed Abramson Cancer Center of the University of Pennsylvania 2018-12-31
NCT01247077 Neuropsychologic and Immunological Evaluation in Treatment of Thyroid Diseases. Is Selenium Efficient? https://ClinicalTrials.gov/show/NCT01247077 Completed Karolinska Institutet 2014-03-31
NCT01240590 A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) https://ClinicalTrials.gov/show/NCT01240590 Completed National Institutes of Health Clinical Center (CC) 2015-08-31
NCT04462471 Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers https://ClinicalTrials.gov/show/NCT04462471 Recruiting Memorial Sloan Kettering Cancer Center 2022-06-30
NCT01236547 Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT01236547 Active, not recruiting National Cancer Institute (NCI) 2020-03-09
NCT01229865 Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT01229865 Completed Vascular Biogenics Ltd. operating as VBL Therapeutics 2014-10-31
NCT01208051 Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer https://ClinicalTrials.gov/show/NCT01208051 Active, not recruiting National Cancer Institute (NCI) 2020-02-01
NCT01189292 Preoperative Single-dose Steroid Application for the Treatment of Nausea and Vomiting After Thyroid Surgery https://ClinicalTrials.gov/show/NCT01189292 Completed Cantonal Hospital of St. Gallen 2013-05-31
NCT01182285 A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin https://ClinicalTrials.gov/show/NCT01182285 Completed National Institutes of Health Clinical Center (CC) 2015-09-28
NCT01164176 Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT01164176 Completed Yonsei University 2014-10-31
NCT01163565 A Prospective Randomized Equivalence Trial to Evaluate the Safety of the Ligasure in Thyroid Surgery https://ClinicalTrials.gov/show/NCT01163565 Completed University of Alberta 2012-09-30
NCT01137097 Lateral Neck Sentinel Lymph Node Biopsy(LSLNB)in PTC https://ClinicalTrials.gov/show/NCT01137097 Completed Samsung Medical Center 2011-01-31
NCT01103557 Prophylactic Selective Lateral Neck Dissection in Patients With Papillary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT01103557 Completed Pusan National University Hospital NA
NCT01100619 A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors https://ClinicalTrials.gov/show/NCT01100619 Completed Exelixis 2012-08-31
NCT01083550 Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01083550 Completed University Health Network, Toronto 2016-11-30
NCT02022319 The Observer Variation of Shear Wave Elastography https://ClinicalTrials.gov/show/NCT02022319 Completed University of Aarhus 2015-12-31
NCT01025453 Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer https://ClinicalTrials.gov/show/NCT01025453 Completed Memorial Sloan Kettering Cancer Center 2018-01-16
NCT01013597 Trial of LBH589 in Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT01013597 Completed University of Wisconsin, Madison 2013-08-31
NCT00984282 Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT00984282 Completed Bayer 2012-08-31
NCT00970359 Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244 https://ClinicalTrials.gov/show/NCT00970359 Completed Memorial Sloan Kettering Cancer Center 2013-04-30
NCT00954057 Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED) https://ClinicalTrials.gov/show/NCT00954057 Completed Neothetics, Inc 2011-06-30
NCT00936858 RAD001 for Patients With Radioiodine Refractory Thyroid Cancer https://ClinicalTrials.gov/show/NCT00936858 Completed Dana-Farber Cancer Institute 2020-02-27
NCT00892164 Thyroid Surgery With the New Harmonic Scalpel or the Electrothermal Bipolar Vessel Sealer https://ClinicalTrials.gov/show/NCT00892164 Completed Hippocration General Hospital 2008-12-31
NCT00887107 Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT00887107 Completed Leiden University Medical Center NA
NCT00858104 Percutaneous Laser Ablation in Benign Thyroid Nodules.Long Term Results https://ClinicalTrials.gov/show/NCT00858104 Completed Elesta S.R.L. 2010-03-31
NCT00846755 Thyroid Disease in Pregnancy: Case Finding Versus Universal Screening https://ClinicalTrials.gov/show/NCT00846755 Completed Ospedale V. Fazzi 2008-03-31
NCT02973997 Lenvatinib and Pembrolizumab in DTC https://ClinicalTrials.gov/show/NCT02973997 Active, not recruiting Academic and Community Cancer Research United 2021-10-08
NCT03085056 Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT03085056 Recruiting Memorial Sloan Kettering Cancer Center 2021-09-30
NCT01788982 Nintedanib(BIBF1120) in Thyroid Cancer https://ClinicalTrials.gov/show/NCT01788982 Active, not recruiting European Organisation for Research and Treatment of Cancer - EORTC 2019-10-31
NCT02867592 Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors https://ClinicalTrials.gov/show/NCT02867592 Recruiting National Cancer Institute (NCI) 2020-09-30
NCT02766660 Optic Disc, Macula, and Retinal Nerve Fiber Layer Measurements Obtained by OCT in Thyroid Associated Ophthalmopathy https://ClinicalTrials.gov/show/NCT02766660 Completed Neon Hospital 2013-01-31
NCT02702388 A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile https://ClinicalTrials.gov/show/NCT02702388 Active, not recruiting Eisai Inc. 2019-12-12
NCT03461211 Treatment of Graves’ Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study https://ClinicalTrials.gov/show/NCT03461211 Active, not recruiting Horizon Pharma USA, Inc. 2020-06-08
NCT03157128 Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT03157128 Recruiting Loxo Oncology, Inc. 2022-03-31
NCT03669432 To Study the Impact of Radiation Treatment After Surgery in Patient With Locally Advanced Thyroid Cancer. https://ClinicalTrials.gov/show/NCT03669432 Recruiting Tata Memorial Hospital 2021-07-31
NCT03573960 A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03573960 Recruiting Eisai Inc. 2020-06-01
NCT01173289 Study of External Beam Radiotherapy to Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT01173289 Completed National Cancer Center, Korea 2015-08-31
NCT00794053 The Usefulness of Staining Lymph Nodes During Operations for Cancer Thyroid in Detecting the Nodes That Have Cancer https://ClinicalTrials.gov/show/NCT00794053 Completed University of Alexandria 2008-12-31
NCT00784407 Thyroid Surgery With the New Harmonic Scalpel: a Prospective Randomized Study https://ClinicalTrials.gov/show/NCT00784407 Completed Hippocration General Hospital 2008-07-31
NCT00784303 Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology https://ClinicalTrials.gov/show/NCT00784303 Completed Eisai Inc. 2011-04-11
NCT00729157 Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy https://ClinicalTrials.gov/show/NCT00729157 Completed National Cancer Institute (NCI) 2012-10-31
NCT00718770 A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression https://ClinicalTrials.gov/show/NCT00718770 Completed University of Colorado, Denver 2013-01-31
NCT00706381 Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs) https://ClinicalTrials.gov/show/NCT00706381 Completed National Institutes of Health Clinical Center (CC) 2012-08-21
NCT00704730 Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT00704730 Active, not recruiting Exelixis 2011-10-31
NCT00673010 Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT00673010 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-03-31
NCT00668811 Sutent Adjunctive Treatment of Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT00668811 Completed Washington Hospital Center 2015-09-30
NCT00661024 Visualization Versus Intraoperative Neuromonitoring of the Recurrent Laryngeal Nerves in Thyroid Surgery https://ClinicalTrials.gov/show/NCT00661024 Completed Jagiellonian University 2007-06-30
NCT00654238 Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer https://ClinicalTrials.gov/show/NCT00654238 Completed University of Pennsylvania 2010-12-31
NCT00625846 Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer https://ClinicalTrials.gov/show/NCT00625846 Completed National Cancer Institute (NCI) 2018-12-21
NCT00615537 Pilot Study on Laser Ablation of Symptomatic Benign Thyroid Masses https://ClinicalTrials.gov/show/NCT00615537 Completed BioTex, Inc. 2011-01-31
NCT00604318 Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer https://ClinicalTrials.gov/show/NCT00604318 Completed Copenhagen University Hospital at Herlev 2012-02-29
NCT00603941 A Phase 1/2 Dose Finding Study of an Experimental New Drug CS7017, an Oral PPARγ Agonist Taken by Mouth Twice Daily in Combination With Paclitaxel Chemotherapy https://ClinicalTrials.gov/show/NCT00603941 Completed Daiichi Sankyo, Inc. 2011-12-31
NCT00569920 Nausea and Pain Prophylaxis During Thyroid Surgery https://ClinicalTrials.gov/show/NCT00569920 Completed Sykehuset Telemark 2008-12-31
NCT00559949 Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine https://ClinicalTrials.gov/show/NCT00559949 Completed National Cancer Institute (NCI) 2016-08-31
NCT00552253 Levothyroxine Treatment in Thyroid Benign Nodular Goiter https://ClinicalTrials.gov/show/NCT00552253 Completed National Taiwan University Hospital 2008-07-31
NCT00537797 Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules https://ClinicalTrials.gov/show/NCT00537797 Completed Washington University School of Medicine 2011-09-30
NCT00537095 Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer https://ClinicalTrials.gov/show/NCT00537095 Active, not recruiting Sanofi 2009-12-31
NCT00519896 Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT00519896 Completed University of Washington 2015-05-31
NCT00514046 Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT00514046 Active, not recruiting National Institutes of Health Clinical Center (CC) 2019-12-10
NCT00510640 Thyroid Cancer and Sunitinib https://ClinicalTrials.gov/show/NCT00510640 Completed University Hospital, Bordeaux 2012-03-31
NCT00472446 Superficial, Cervical Block in Thyroid Surgery, a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT00472446 Completed Cantonal Hospital of St. Gallen 2008-12-31
NCT00470496 Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00470496 Completed Roswell Park Cancer Institute 2011-10-28
NCT00467506 Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT00467506 Completed Nantes University Hospital 2011-01-31
NCT00415233 High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT00415233 Active, not recruiting University College, London 2011-06-30
NCT00410761 An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT00410761 Active, not recruiting Sanofi 2009-07-31
NCT00400465 Is the Routine Pressure Dressing After Thyroidectomy Necessary? https://ClinicalTrials.gov/show/NCT00400465 Completed Khon Kaen University 2007-08-31
NCT00390325 Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT00390325 Active, not recruiting National Cancer Institute (NCI) 2017-01-30
NCT00389441 Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer https://ClinicalTrials.gov/show/NCT00389441 Completed Pfizer 2012-09-30
NCT00381641 Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00381641 Active, not recruiting National Cancer Institute (NCI) 2016-12-31
NCT00358956 A Study To Assess ZD6474 (ZACTIMAâ„¢) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT00358956 Completed Sanofi 2008-01-31
NCT00295763 A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen. https://ClinicalTrials.gov/show/NCT00295763 Completed Sanofi 2006-07-31
NCT00287287 REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas https://ClinicalTrials.gov/show/NCT00287287 Completed University of Kentucky 2010-07-06
NCT00279721 Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer. https://ClinicalTrials.gov/show/NCT00279721 Completed AHS Cancer Control Alberta 2010-06-30
NCT00251316 Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer https://ClinicalTrials.gov/show/NCT00251316 Completed National Institutes of Health Clinical Center (CC) 2011-12-31
NCT00223158 Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer https://ClinicalTrials.gov/show/NCT00223158 Completed Université de Sherbrooke 2005-05-31
NCT00196729 Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration https://ClinicalTrials.gov/show/NCT00196729 Completed Sanofi NA
NCT00181168 Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer https://ClinicalTrials.gov/show/NCT00181168 Completed Johns Hopkins University 2003-09-30
NCT00176748 Treatment for Patients With Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT00176748 Completed University of Michigan Rogel Cancer Center 2006-08-31
NCT00144079 Multicenter Study Differentiated Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT00144079 Completed University Hospital Muenster NA
NCT00134043 Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer https://ClinicalTrials.gov/show/NCT00134043 Completed National Cancer Institute (NCI) 2009-03-31
NCT00124527 Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer https://ClinicalTrials.gov/show/NCT00124527 Completed Eisai Inc. NA
NCT00121628 A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT00121628 Completed Amgen 2006-11-30
NCT00118248 Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT00118248 Completed National Cancer Institute (NCI) 2009-08-31
NCT00115895 The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy https://ClinicalTrials.gov/show/NCT00115895 Active, not recruiting University of Helsinki 2004-10-31
NCT00106119 Thyroid and Glucose and Energy Metabolism https://ClinicalTrials.gov/show/NCT00106119 Completed National Institutes of Health Clinical Center (CC) 2013-11-30
NCT00104871 Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy https://ClinicalTrials.gov/show/NCT00104871 Completed National Cancer Institute (NCI) 2010-05-31
NCT00098813 Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine https://ClinicalTrials.gov/show/NCT00098813 Completed National Cancer Institute (NCI) 2009-08-31
NCT00098345 Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer https://ClinicalTrials.gov/show/NCT00098345 Completed Sanofi 2008-02-29
NCT00095836 Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy https://ClinicalTrials.gov/show/NCT00095836 Completed Massachusetts General Hospital 2011-03-31
NCT00094055 Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT00094055 Completed Pfizer 2009-01-31
NCT00085293 Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 https://ClinicalTrials.gov/show/NCT00085293 Completed National Cancer Institute (NCI) 2014-01-31
NCT00004062 Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT00004062 Completed National Cancer Institute (NCI) NA
NCT00080574 The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients https://ClinicalTrials.gov/show/NCT00080574 Completed National Institutes of Health Clinical Center (CC) NA
NCT00004074 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu https://ClinicalTrials.gov/show/NCT00004074 Completed National Cancer Institute (NCI) 2009-02-28
NCT00068497 Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00068497 Completed National Cancer Institute (NCI) 2007-12-31
NCT00795782 Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma https://ClinicalTrials.gov/show/NCT00795782 Completed Samsung Medical Center 2012-06-30
NCT00061906 Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT00061906 Completed Ohio State University Comprehensive Cancer Center 2006-06-30
NCT00054756 Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities https://ClinicalTrials.gov/show/NCT00054756 Completed National Institutes of Health Clinical Center (CC) 2014-09-26
NCT00001730 Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal. https://ClinicalTrials.gov/show/NCT00001730 Completed National Institutes of Health Clinical Center (CC) NA
NCT00026533 Thalidomide in Treating Patients With Thyroid Cancer https://ClinicalTrials.gov/show/NCT00026533 Completed University of Kentucky 2003-11-30

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04216732 Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management https://ClinicalTrials.gov/show/NCT04216732 Recruiting M.D. Anderson Cancer Center 2022-09-01
NCT03397238 Myeloid Cell Reprogramming in Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT03397238 Recruiting Radboud University 2020-06-30
NCT03392402 Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules https://ClinicalTrials.gov/show/NCT03392402 Recruiting Maria Sklodowska-Curie Institute - Oncology Center 2020-03-31
NCT03390582 Gut Microbiota is Associated With Autoimmune Thyroid Disease https://ClinicalTrials.gov/show/NCT03390582 Recruiting First Affiliated Hospital of Harbin Medical University 2018-12-24
NCT03369405 Thyroid Disease and Chronic Periodontitis https://ClinicalTrials.gov/show/NCT03369405 Active, not recruiting University at Buffalo 2021-08-01
NCT03363347 BRAF V600E and Redifferentiation Therapy in Radioiodine-refractory Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT03363347 Completed Heidelberg University 2014-12-31
NCT03307694 Thyroid Ultrasound Elasticity (TrUE) Imaging https://ClinicalTrials.gov/show/NCT03307694 Completed Emory University 2018-07-13
NCT03300284 Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT03300284 Recruiting Memorial Sloan Kettering Cancer Center 2021-08-31
NCT03294005 Clinical Prediction Thyroid Cancer With Thyroid Ultrasonography https://ClinicalTrials.gov/show/NCT03294005 Active, not recruiting China Medical University Hospital 2019-06-26
NCT03284840 Adults Nutrition as a Protective or Health-risk Factor https://ClinicalTrials.gov/show/NCT03284840 Active, not recruiting Nutrition Institute, Slovenia 2018-09-13
NCT03271892 Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT03271892 Recruiting University Health Network, Toronto 2026-05-11
NCT03160482 PACE4 in Thyroid Cancer https://ClinicalTrials.gov/show/NCT03160482 Completed Université de Sherbrooke 2018-01-15
NCT03110835 Low-dose Radioiodine Ablation in Graves’ Disease https://ClinicalTrials.gov/show/NCT03110835 Completed University of Pisa 2017-03-28
NCT03001336 Thyroid Function and Diabetes Complications https://ClinicalTrials.gov/show/NCT03001336 Completed Nanjing First Hospital, Nanjing Medical University 2012-12-31
NCT02952612 Active Surveillance of Papillary Thyroid Microcarcinoma https://ClinicalTrials.gov/show/NCT02952612 Recruiting Seoul St. Mary’s Hospital 2017-10-31
NCT02938702 Active Surveillance on Papillary Thyroid Microcarcinoma https://ClinicalTrials.gov/show/NCT02938702 Active, not recruiting Seoul National University Hospital 2025-03-31
NCT02886949 The Association Between Autoimmune or Inflammation and Thyroid Disease https://ClinicalTrials.gov/show/NCT02886949 Recruiting Taichung Veterans General Hospital 2020-12-31
NCT02813733 Determinants of Thyroid Surgery Outcomes https://ClinicalTrials.gov/show/NCT02813733 Completed Hospices Civils de Lyon 2009-12-31
NCT02776969 A Gene Hunting Study for Familial Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT02776969 Recruiting Ohio State University Comprehensive Cancer Center 2021-12-31
NCT02773667 Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine https://ClinicalTrials.gov/show/NCT02773667 Recruiting Jena University Hospital 2020-12-31
NCT02681328 Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules https://ClinicalTrials.gov/show/NCT02681328 Recruiting Jonsson Comprehensive Cancer Center 2021-08-01
NCT02658513 Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer https://ClinicalTrials.gov/show/NCT02658513 Completed Royal Surrey County Hospital NHS Foundation Trust 2019-03-31
NCT01109420 Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01109420 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00001160 Studies on Tumors of the Thyroid https://ClinicalTrials.gov/show/NCT00001160 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01441154 Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment https://ClinicalTrials.gov/show/NCT01441154 Completed National Institutes of Health Clinical Center (CC) NA
NCT02555332 Maternal Thyroid Function in Early Pregnancy and Their Relationship With Gestational Diabetes Mellitus https://ClinicalTrials.gov/show/NCT02555332 Completed Shanghai First Maternity and Infant Hospital 2014-03-31
NCT02491567 DNA Methylation and Autoimmune Thyroid Diseases https://ClinicalTrials.gov/show/NCT02491567 Completed Aristotle University Of Thessaloniki 2016-09-30
NCT02465424 Assessing Quality of Life Tools in Medullary Thyroid Cancer Patients https://ClinicalTrials.gov/show/NCT02465424 Completed Velindre NHS Trust 2017-12-31
NCT02442661 Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT02442661 Completed University of Colorado, Denver 2016-12-31
NCT02430714 Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T) https://ClinicalTrials.gov/show/NCT02430714 Completed Eisai Inc. 2016-11-06
NCT02377882 The Optimal Dosage of Rocuronium for Intraoperative Neuromonitoring During Thyroid Surgery https://ClinicalTrials.gov/show/NCT02377882 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2009-12-31
NCT02352766 Role of NGS-based ThyroSeq Panel in Cancer Diagnosis in Thyroid Nodules https://ClinicalTrials.gov/show/NCT02352766 Completed University of Pittsburgh 2019-02-15
NCT02323724 APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS. https://ClinicalTrials.gov/show/NCT02323724 Completed Corporacion Parc Tauli 2015-07-31
NCT02307175 A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication https://ClinicalTrials.gov/show/NCT02307175 Completed Centre de recherche du Centre hospitalier universitaire de Sherbrooke 2016-08-31
NCT02303444 An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors https://ClinicalTrials.gov/show/NCT02303444 Active, not recruiting Bayer 2020-07-08
NCT02194920 Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function https://ClinicalTrials.gov/show/NCT02194920 Completed University of Roma La Sapienza 2014-10-31
NCT02190214 Thyroid Disorders in Malaysia: A Nationwide Multicentre Study https://ClinicalTrials.gov/show/NCT02190214 Completed International Islamic University Malaysia 2016-09-30
NCT02185560 Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib https://ClinicalTrials.gov/show/NCT02185560 Active, not recruiting Bayer 2020-02-27
NCT02061111 NeoThyr - the Role of Mitochondria-dysfunction in Newborns of Mothers With Autoimmune Thyroid Disease https://ClinicalTrials.gov/show/NCT02061111 Active, not recruiting Naestved Hospital 2017-12-31
NCT01306916 Coexisting Thyroid Disease and Hyperparathyroidism https://ClinicalTrials.gov/show/NCT01306916 Completed Walter Reed Army Medical Center 2010-12-31
NCT01270425 Sonographic and Laboratory Evaluation of the Thyroid Gland in Patients With Systemic Sclerosis https://ClinicalTrials.gov/show/NCT01270425 Completed Meir Medical Center 2011-12-31
NCT03083405 Selected Disorders and Sleep Bruxism https://ClinicalTrials.gov/show/NCT03083405 Enrolling by invitation Wroclaw Medical University 2020-09-30
NCT01969552 Interrelations Between FT3, FT4 and Pituitary TSH https://ClinicalTrials.gov/show/NCT01969552 Completed Klinikum Lüdenscheid 2014-06-30
NCT01954134 P53 in Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT01954134 Completed Cumhuriyet University 2013-01-31
NCT01945762 Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01945762 Recruiting Sanofi 2019-09-30
NCT01736163 A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours https://ClinicalTrials.gov/show/NCT01736163 Completed Sanofi 2012-08-31
NCT01690806 Dexamethasone for the Prevention of Recurrent Laryngeal Nerve Palsy https://ClinicalTrials.gov/show/NCT01690806 Completed Università degli Studi dell’Aquila 2012-01-31
NCT01660984 Natural History Study of Children and Adults With Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01660984 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01659385 Leptin Levels in Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01659385 Completed University of Nebraska 2013-06-30
NCT01648569 Long-term Outcomes of Total Thyroidectomy Versus Less Than Total Thyroidectomy for Papillary Thyroid Microcarcinoma https://ClinicalTrials.gov/show/NCT01648569 Completed Korean Association of Endocrine Surgeons 2012-05-31
NCT01586520 Diagnosing Thyroid Cancer Using a Blood Test https://ClinicalTrials.gov/show/NCT01586520 Completed Newcastle-upon-Tyne Hospitals NHS Trust 2014-10-31
NCT01539499 Complications of Endocrine Surgery: Data From the United HealthSystem Consortium https://ClinicalTrials.gov/show/NCT01539499 Completed University of Arkansas 2017-08-31
NCT01528904 Maternal Autoimmune Thyroid Disease and Fetal Thyroxin https://ClinicalTrials.gov/show/NCT01528904 Completed University of Belgrade 2011-03-31
NCT01487057 Lipid Metabolic Status in Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT01487057 Completed Prof. Dr. I. Chiricuta Institute of Oncology 2012-02-29
NCT01466023 The Reduced Thyroid Function of the Premature Newborn: Relation With Molecular Changes in the Placenta and Maternal Thyroid Hormone Status and Neurodevelopmental Implications https://ClinicalTrials.gov/show/NCT01466023 Completed Universitaire Ziekenhuizen Leuven 2014-04-30
NCT01433809 Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm https://ClinicalTrials.gov/show/NCT01433809 Completed Mayo Clinic 2013-05-31
NCT01428167 Hashimotos Thyroiditis and Thyroid Cancer https://ClinicalTrials.gov/show/NCT01428167 Completed The University of Texas Medical Branch, Galveston 2012-05-31
NCT01424878 Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients https://ClinicalTrials.gov/show/NCT01424878 Completed National Institutes of Health Clinical Center (CC) NA
NCT01412762 Measuring Patient Expectations for Thyroid Surgery https://ClinicalTrials.gov/show/NCT01412762 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-07-31
NCT01401855 Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules https://ClinicalTrials.gov/show/NCT01401855 Completed Boston Medical Center 2014-06-30
NCT01384786 The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter https://ClinicalTrials.gov/show/NCT01384786 Completed Copenhagen University Hospital at Herlev NA
NCT01384669 Genetic Expression Alteration Affect on Lateral Neck Node Metastasis of Thyroid Papillary Microcarcinoma : Microarray Analysis https://ClinicalTrials.gov/show/NCT01384669 Completed Yonsei University 2013-05-26
NCT04433936 Corneal Tomographic Parameters in TGD https://ClinicalTrials.gov/show/NCT04433936 Completed Mansoura University 2018-06-01
NCT04411290 Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases https://ClinicalTrials.gov/show/NCT04411290 Enrolling by invitation Umraniye Education and Research Hospital 2021-06-01
NCT04406779 The Frequency of Thyroid Diseases in Women With Breast Cancer https://ClinicalTrials.gov/show/NCT04406779 Completed UÅŸak University 2017-03-31
NCT04396912 Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort https://ClinicalTrials.gov/show/NCT04396912 Recruiting Umraniye Education and Research Hospital 2021-06-01
NCT04346992 Prevalence Of Keratoconus Among Patients With Thyroid Gland Dysfunction https://ClinicalTrials.gov/show/NCT04346992 Recruiting Fayoum University 2020-08-31
NCT04313101 Association Between Thyroid Dysfunction and Intensive Care Unit Acquired Weaknesss https://ClinicalTrials.gov/show/NCT04313101 Recruiting Ain Shams University 2020-05-31
NCT04279184 Urinary Incontinence and Endocrine Factors. A Part of Lolland-Falster Health Study (LOFUS). https://ClinicalTrials.gov/show/NCT04279184 Recruiting Nykøbing Falster County Hospital 2020-02-29
NCT04274829 Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid https://ClinicalTrials.gov/show/NCT04274829 Completed University of Cagliari 2018-01-31
NCT04249271 Antithyroidal Antibodies With or Without Subclinical Hypothyroidism During Pregnancy in Infertile Women https://ClinicalTrials.gov/show/NCT04249271 Completed University Hospital, Basel, Switzerland 2019-12-31
NCT04248114 Skin-crease Thyroidectomy https://ClinicalTrials.gov/show/NCT04248114 Completed Western Galilee Hospital-Nahariya 2018-08-31
NCT04167423 Mapping Health-related Quality of Life in Pregnant Women With Thyroid Disease. https://ClinicalTrials.gov/show/NCT04167423 Recruiting Value Outcomes Ltd. 2021-01-31
NCT04139096 Genetic Susceptibility to Radiation Induced Thyroid Cancer https://ClinicalTrials.gov/show/NCT04139096 Recruiting Institut National de la Santé Et de la Recherche Médicale, France 2020-04-30
NCT04133870 Identification of Molecular Biomarkers for Thyroid Cancer https://ClinicalTrials.gov/show/NCT04133870 Active, not recruiting Royal Marsden NHS Foundation Trust 2018-04-30
NCT04076514 The Role of Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT04076514 Recruiting Assiut University 2020-09-30
NCT04075851 The Prevalence of Serum Thyroid Hormone Autoantibodies in Autoimmune Thyroid Diseases https://ClinicalTrials.gov/show/NCT04075851 Recruiting Shandong Provincial Hospital 2022-08-01
NCT04072731 SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer https://ClinicalTrials.gov/show/NCT04072731 Completed People’s Hospital of Zhengzhou University 2017-07-30
NCT04031638 Thyroid Cancer Database https://ClinicalTrials.gov/show/NCT04031638 Recruiting Centre Georges Francois Leclerc 2025-01-01
NCT04031339 Study of Clinical Outcomes of Thyroid Cancer https://ClinicalTrials.gov/show/NCT04031339 Recruiting University of Roma La Sapienza 2025-01-31
NCT03984006 Early Detection of Autoimmune Thyroid Heart Disease Via Urinary Exosomal Proteins https://ClinicalTrials.gov/show/NCT03984006 Recruiting National Taiwan University Hospital 2020-05-28
NCT03157466 Respiratory Muscle Function After Thyroid Hormone Replacement Therapy in Nonthyroidal Illness Syndrome https://ClinicalTrials.gov/show/NCT03157466 Completed Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2018-05-01
NCT03933358 Effect of Thyroid Hormone on Post-Myocardial Infarction Remodeling and Prognosis in STEMI Patients https://ClinicalTrials.gov/show/NCT03933358 Recruiting Beijing Friendship Hospital 2021-06-30
NCT03932487 The Relationship Between Urine Iodine, Urine Bisphenol A and Autoimmune Thyroid Disease in Reproductive Women https://ClinicalTrials.gov/show/NCT03932487 Recruiting Peking University International Hospital 2022-10-01
NCT03922087 No-worry Baby Project https://ClinicalTrials.gov/show/NCT03922087 Recruiting Sun Yat-sen University 2021-12-31
NCT03889769 Evaluation of Accuracy of One-Step Nucleic Acid Amplification (OSNA) in Diagnosis of Lymph Node Metastases of Papillary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT03889769 Recruiting University of Cagliari 2019-04-01
NCT03887611 Application of Ultrasound Artificial Intelligence and Elastography in Differential Diagnosis of Thyroid Nodules https://ClinicalTrials.gov/show/NCT03887611 Recruiting Tongji Hospital 2020-01-18
NCT03880578 Quality of Life After Surgery and Radioiodine Treatment https://ClinicalTrials.gov/show/NCT03880578 Recruiting Klinikum Lüdenscheid 2020-12-31
NCT03787121 Estimation of Economic Consequences Linked With Different Care Management Pathways of Differentiated Thyroid Cancers https://ClinicalTrials.gov/show/NCT03787121 Recruiting University Hospital, Toulouse 2021-12-31
NCT03765333 GETNE Registration of Thyroid Cancer https://ClinicalTrials.gov/show/NCT03765333 Recruiting Grupo Espanol de Tumores Neuroendocrinos 2020-05-31
NCT03754621 Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey https://ClinicalTrials.gov/show/NCT03754621 Recruiting Bartin State Hospital 2019-07-02
NCT03676647 Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules https://ClinicalTrials.gov/show/NCT03676647 Recruiting City of Hope Medical Center 2028-12-27
NCT03663517 Gestational Age Specific Thyroid Function Reference Range https://ClinicalTrials.gov/show/NCT03663517 Completed Chinese University of Hong Kong 2016-04-30
NCT03657654 Voice Outcomes Following Thyroidectomy https://ClinicalTrials.gov/show/NCT03657654 Recruiting University of Virginia 2020-07-15
NCT03643055 18F-Fluorocholine PET/CT in Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT03643055 Recruiting University Medical Centre Ljubljana 2020-09-03
NCT03624751 Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment https://ClinicalTrials.gov/show/NCT03624751 Recruiting Taichung Veterans General Hospital 2028-06-30
NCT03623516 Overdiagnosis of Thyroid Cancer in the Marne and Ardennes Departments of France From 1975 to 2014 https://ClinicalTrials.gov/show/NCT03623516 Completed CHU de Reims 2014-12-01
NCT03598283 Liver, Pancreas and Thyroid Function in Burn Patients https://ClinicalTrials.gov/show/NCT03598283 Recruiting The University of Texas Medical Branch, Galveston 2019-06-30
NCT03597659 PheWAS of a Polygenic Predictor of Thyroid Function https://ClinicalTrials.gov/show/NCT03597659 Completed Groupe Hospitalier Pitie-Salpetriere 2018-07-01
NCT03578601 Predictive Parameters for Difficult Tracheal Intubation Identification in Thyroid Surgery https://ClinicalTrials.gov/show/NCT03578601 Completed University of Padova 2018-09-17
NCT03515863 Natural History and Risk Factors of TAO https://ClinicalTrials.gov/show/NCT03515863 Recruiting Sun Yat-sen University 2021-05-09
NCT03460912 Different Types of Electrostimulation Probes During IONM https://ClinicalTrials.gov/show/NCT03460912 Completed Ege University 2016-12-26
NCT03426696 Psychological Status and Related Factors of Thyroid Related Eye Disease https://ClinicalTrials.gov/show/NCT03426696 Completed Sun Yat-sen University 2018-12-01
NCT03414021 Interest of the SPECT-CT Scan SUVspect in the New Generation of Gamma-cameras With Semiconductor https://ClinicalTrials.gov/show/NCT03414021 Recruiting Lille Catholic University 2023-01-30
NCT01227499 Differential Diagnosis of STA-PSV in Thyrotoxicosis https://ClinicalTrials.gov/show/NCT01227499 Completed Huashan Hospital 2011-11-30
NCT01102127 Elastography in Thyroid Nodules https://ClinicalTrials.gov/show/NCT01102127 Completed Castilla-León Health Service 2010-09-30
NCT01089335 Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia https://ClinicalTrials.gov/show/NCT01089335 Completed Region Skane 2018-12-31
NCT00958113 Autoimmune Thyroid Disease Genetic Study https://ClinicalTrials.gov/show/NCT00958113 Completed University of Colorado, Denver 2013-02-28
NCT00871130 The Effect of Bariatric Surgery on Thyroid Function and Morphology https://ClinicalTrials.gov/show/NCT00871130 Completed University Hospital Inselspital, Berne 2007-12-31
NCT02645786 Thyrotropin Over-suppression and Heart https://ClinicalTrials.gov/show/NCT02645786 Completed Chuncheon Sacred Heart Hospital 2013-11-30
NCT00812149 Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3 https://ClinicalTrials.gov/show/NCT00812149 Completed National Institutes of Health Clinical Center (CC) NA
NCT01792492 The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study https://ClinicalTrials.gov/show/NCT01792492 Completed Boston Medical Center 2010-03-31
NCT00341094 Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident https://ClinicalTrials.gov/show/NCT00341094 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT03191643 PET-guided External Beam Radiotherapy in Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03191643 Completed Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi 2016-01-31
NCT03061318 Validation of a Multi-Genetic Test for the Diagnosis of Indeterminate Thyroid Nodules https://ClinicalTrials.gov/show/NCT03061318 Completed Pontificia Universidad Catolica de Chile 2017-08-30
NCT02178345 Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT02178345 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-06-30
NCT04288531 Iodine Impact on Thyroid Function and Psychomotor Development, Observational Study in the Portuguese Minho Region https://ClinicalTrials.gov/show/NCT04288531 Recruiting University of Minho 2024-01-10
NCT03676348 HRQOL in Thyroid Cancer and Thyroid Tumours https://ClinicalTrials.gov/show/NCT03676348 Recruiting Oslo University Hospital 2023-01-31
NCT00719615 Assess Vitamin D Levels in Those With & Without Thyroid Cancer https://ClinicalTrials.gov/show/NCT00719615 Completed University of Nebraska 2009-03-31
NCT00666315 Harmonic FOCUS Versus Conventional Technique in Total Thyroidectomy for Benign Thyroid Disease https://ClinicalTrials.gov/show/NCT00666315 Completed Ethicon Endo-Surgery (Europe) GmbH 2008-04-30
NCT00592605 Thyroid Disease Serum Repository https://ClinicalTrials.gov/show/NCT00592605 Completed University of Arkansas 2017-06-01
NCT00592514 Thyroid Dysfunction in Head and Neck Surgery Patients https://ClinicalTrials.gov/show/NCT00592514 Completed University of Arkansas 2008-07-31
NCT00571090 Prediction of Thyroid Cancer From Ultrasonographic Characteristics of Thyroid Nodules https://ClinicalTrials.gov/show/NCT00571090 Completed Istanbul Science University 2012-07-31
NCT00571077 Electrical Impedance Scanning of Thyroid Nodules Prior to Thyroid Surgery: a Prospective Study https://ClinicalTrials.gov/show/NCT00571077 Completed Hadassah Medical Organization NA
NCT00551486 Pyrosequencing of the BRAFV600E Mutation https://ClinicalTrials.gov/show/NCT00551486 Completed Chungnam National University NA
NCT00485446 Thrombophilia and Thyroid Autoimmunity in Implantation Failure and Recurrent Miscarriage https://ClinicalTrials.gov/show/NCT00485446 Completed Instituto Valenciano de Infertilidad, IVI VALENCIA NA
NCT00480428 Radiation Exposure and Thyroid Disease in Kazakhstan https://ClinicalTrials.gov/show/NCT00480428 Completed National Institutes of Health Clinical Center (CC) NA
NCT00459498 Expression of NIS Protein and mRNA in Thyroid Tumors https://ClinicalTrials.gov/show/NCT00459498 Completed University of Sao Paulo NA
NCT00459459 Prognostic Significance of Fine-Needle Aspiration Cytology Features in Papillary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT00459459 Completed National Taiwan University Hospital NA
NCT00454077 rhTSH-Thyroid Ablation With 1850 MBq of 131I https://ClinicalTrials.gov/show/NCT00454077 Completed University of Siena NA
NCT00439478 Dental Safety Profile of High-Dose Radioiodine Therapy https://ClinicalTrials.gov/show/NCT00439478 Completed University Hospital, Basel, Switzerland NA
NCT00439127 OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation https://ClinicalTrials.gov/show/NCT00439127 Completed Oncology Institute of Southern Switzerland NA
NCT00437931 Color Flow Doppler Ultrasound in Subclinical Thyroid Dysfunction https://ClinicalTrials.gov/show/NCT00437931 Completed HaEmek Medical Center, Israel 2008-02-29
NCT00341185 Studies of Thyroid Abnormalities in Northeastern Kazakhstan Associated With Nuclear Weapons Testing https://ClinicalTrials.gov/show/NCT00341185 Completed National Institutes of Health Clinical Center (CC) NA
NCT00339716 Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident https://ClinicalTrials.gov/show/NCT00339716 Completed National Institutes of Health Clinical Center (CC) 2020-03-11
NCT00293956 Thyroid Function in Term Infants With Respiratory Distress https://ClinicalTrials.gov/show/NCT00293956 Completed Christiana Care Health Services 2006-07-31
NCT00280852 Review of Multimodality Management of Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT00280852 Completed AHS Cancer Control Alberta 2006-06-30
NCT00150033 Health-Related Quality of Life for Thyroid Patients https://ClinicalTrials.gov/show/NCT00150033 Completed Odense University Hospital NA
NCT00148213 Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT00148213 Completed University Hospital Muenster NA
NCT00043238 Mohawk Culture, Behavior, Toxicant Exposure and Health https://ClinicalTrials.gov/show/NCT00043238 Completed National Institute of Environmental Health Sciences (NIEHS) 2005-07-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03031639 Khon Kaen University’s Thyroidectomy Registry https://ClinicalTrials.gov/show/NCT03031639 Recruiting Khon Kaen University 2021-01-13
NCT02966405 The Establish of Specific Reference Ranges for Thyroid Tests in Pregnant Women https://ClinicalTrials.gov/show/NCT02966405 Recruiting Peking University International Hospital 2020-08-31
NCT02869620 Institut Paoli Calmettes Thyroid Cancer Database https://ClinicalTrials.gov/show/NCT02869620 Recruiting Institut Paoli-Calmettes 2030-01-31
NCT02868476 Long Period Observation of Biochemical Survey and Ultrasonography in Thyroid Diseases and Subclinical Thyroid Diseases https://ClinicalTrials.gov/show/NCT02868476 Active, not recruiting National Taiwan University Hospital 2017-05-26
NCT02862470 Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients https://ClinicalTrials.gov/show/NCT02862470 Active, not recruiting National Taiwan University Hospital 2018-10-31
NCT01838629 the Effect of Universal Salt Iodization on Thyroid Diseases https://ClinicalTrials.gov/show/NCT01838629 Completed Hangzhou Center of Disease Control and Prevention 2012-06-30
NCT01511393 An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) https://ClinicalTrials.gov/show/NCT01511393 Enrolling by invitation United BioSource, LLC 2035-12-31
NCT04388956 Thyroid Disease Diagnosis by Mutiple Ultrasonic Factors. https://ClinicalTrials.gov/show/NCT04388956 Recruiting National Taiwan University Hospital 2016-12-31
NCT04208503 Ultrasound and Functional Thyroid Evaluation https://ClinicalTrials.gov/show/NCT04208503 Recruiting Princess Anna Mazowiecka Hospital, Warsaw, Poland 2021-12-30
NCT03517267 Thyroid Imaging Reporting and Data System (TIRADS ) Versus Thyroid Association (ATA) Guidelines https://ClinicalTrials.gov/show/NCT03517267 Recruiting Rambam Health Care Campus 2019-06-30
NCT03488134 Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3 https://ClinicalTrials.gov/show/NCT03488134 Active, not recruiting National Taiwan University Hospital 2021-07-31
NCT01774279 interNational Anaplastic Thyroid Cancer Tissue Bank and Database (iNATT) https://ClinicalTrials.gov/show/NCT01774279 Recruiting Velindre NHS Trust 2022-02-28
NCT00598364 Molecular Markers in Thyroid Cancer https://ClinicalTrials.gov/show/NCT00598364 Completed OHSU Knight Cancer Institute 2010-10-31